chr2-208437864-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005048.4(PTH2R):c.394G>A(p.Asp132Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000626 in 1,613,430 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005048.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PTH2R | NM_005048.4 | c.394G>A | p.Asp132Asn | missense_variant | 4/13 | ENST00000272847.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PTH2R | ENST00000272847.7 | c.394G>A | p.Asp132Asn | missense_variant | 4/13 | 1 | NM_005048.4 | P1 | |
PTH2R | ENST00000617735.4 | c.61G>A | p.Asp21Asn | missense_variant | 4/13 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000104 AC: 26AN: 251120Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135724
GnomAD4 exome AF: 0.0000609 AC: 89AN: 1461276Hom.: 0 Cov.: 31 AF XY: 0.0000660 AC XY: 48AN XY: 726884
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 22, 2023 | The c.394G>A (p.D132N) alteration is located in exon 4 (coding exon 4) of the PTH2R gene. This alteration results from a G to A substitution at nucleotide position 394, causing the aspartic acid (D) at amino acid position 132 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at